Provided by Tiger Trade Technology Pte. Ltd.

Amgen

382.47
-8.8000-2.25%
Post-market: 382.790.3187+0.08%17:23 EDT
Volume:3.41M
Turnover:1.31B
Market Cap:205.95B
PE:23.76
High:391.67
Open:387.84
Low:381.51
Close:391.27
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.10
T/O Rate:0.63%
Dividend:9.80
Dividend Rate:2.56%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:17.62
PE(LYR):26.88

Loading ...

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Amgen Rises 3.05% in Regular Trading, Morgan Stanley and Mizuho Raise Target Prices Amid Biotech Sector Strength

Market Focus
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Amgen is Maintained at Buy by Argus Research

Dow Jones
·
Aug 19

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Reuters
·
Aug 19

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS
·
Aug 19

Morgan Stanley Adjusts Price Target on Amgen to $362 From $351, Keeps Equalweight Rating

MT Newswires Live
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

TScan Therapeutics Faces Loss of Key Amgen Partnership

TIPRANKS
·
Aug 19

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS
·
Aug 19

The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 Beat - Learn Why

Simply Wall St.
·
Aug 19

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Dow Jones
·
Aug 18

Amgen Price Target Raised to $400.00/Share from $350.00 by Cantor Fitzgerald

Dow Jones
·
Aug 18

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

TIPRANKS
·
Aug 15

Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

TIPRANKS
·
Aug 15

Amgen Price Target Raised to $380.00/Share from $360.00 by Barclays

Dow Jones
·
Aug 14

Barclays Reaffirms Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
Aug 14